论文部分内容阅读
Objective To evaluate the predictive value of serum levels of PD-1, IL-17, and IL-21 in patients with nonsmall cell lung cancer. Methods Serum levels of PD-1, IL-17, and IL-21 were analyzed by ELISA in 45 patients with non-small cell lung cancer (NSCLC) a